Form C received from Mr. Jay Arvind Bhanushali, Promoters Immediate Relative for the acquisition of equity shares from the market as on May 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Jay Arvind Bhanushali, an immediate relative of the company's promoter, purchased 150 equity shares of Aspira Pathlab & Diagnostics Ltd from the open market on May 30, 2025, through BSE. The total transaction value was ₹7,732.50 (approximately ₹51.55 per share). His shareholding rose marginally from 2,32,577 shares to 2,32,727 shares, keeping his stake unchanged at 2.26%. The disclosure was made under SEBI Insider Trading Regulations, with the company receiving Form C on June 2, 2025.
The purchase is very small in both volume and value, so it is unlikely to have any meaningful impact on the stock price. It signals minor insider confidence but does not materially change the promoter group's overall holding.